NYSEARCA:PBE Invesco Biotechnology & Genome ETF (PBE) Price, Holdings, & News $70.84 +0.74 (+1.06%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$70.52▼$71.1950-Day Range$62.25▼$70.8452-Week Range$52.47▼$71.19Volume19,934 shsAverage Volume12,469 shsMarket Capitalization$286.21 millionAssets Under Management$269.61 millionDividend Yield0.06%Net Expense Ratio0.58% Stock AnalysisStock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsStock AnalysisChartDividendHeadlinesHoldingsOwnershipRatings Get Invesco Biotechnology & Genome ETF alerts: Email Address About Invesco Biotechnology & Genome ETF (NYSEARCA:PBE)PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies. The Fund will normally invest at least 90% of its total assets in common stocks that consists of the Index. The Index is designed to provide capital appreciation by evaluating companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. Invesco PowerShares Capital Management LLC acts as the Fund’s investment adviser.Read More PBE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PBE ETF News HeadlinesMarch 22, 2024 | msn.comInvesco Dynamic Biotechnology & Genome ETF declares quarterly distribution of $0.0242February 19, 2024 | investorplace.com3 Biotech Stocks to Buy That Have CRISPR-Like Breakthrough PotentialJuly 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.February 14, 2024 | msn.comWhere Are Biotech ETFs Headed After Q4 Earnings?December 22, 2023 | uk.investing.comInvesco MSCI USA ESG Universal Screened UCITS ETF USD DistributionDecember 14, 2023 | uk.investing.comInvesco Markets plc - Invesco S&P China A 300 Swap UCITS ETFNovember 27, 2023 | lse.co.ukInvesco Nasdaq Biotech Ucits Etf Share Price (SBIO.AM)November 25, 2023 | wsj.comInvesco Biotechnology & Genome ETFJuly 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.November 16, 2023 | lse.co.ukInvesco Msci World Esg Screen Ucits Etf Share Price (ESGW.MI)See More Headlines Receive PBE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerInvesco Fund NameInvesco Biotechnology & Genome ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:PBE Inception Date6/23/2005 Fund ManagerPeter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser Webwww.invescopowershares.com Phone+1-800-9830903Fund Focus Asset ClassEquity BenchmarkDynamic Biotech & Genome Intellidex Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings31 Fund Statistics Assets Under Management$269.61 million Average Daily Volume$12,481.30 Discount/Premium0.07% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorInvesco Capital Management LLC CustodianThe Bank of New York Mellon Corporation DistributorInvesco Distributors, Inc. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerCitadel Options OptionableN/A Short Interest600 shs Miscellaneous Outstanding Shares4,040,000Beta0.88 Creation Unit10,000 Creation Fee$500.00 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Invesco Biotechnology & Genome ETF ExpensesTypePBEHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.50%0.56%0.54%0.51%0.51%Other Expenses0.08%0.33%0.50%0.59%0.54%Total Expense0.58%0.70%0.70%0.74%0.71%Fee Waiver0.00%-0.45%-0.54%-0.69%-0.59%Net Expense0.58%0.61%0.60%0.58%0.58% Invesco Biotechnology & Genome ETF (PBE) Holdings & ExposureTop 10 PBE HoldingsBioMarin Pharmaceutical(NASDAQ:BMRN)Holding Weight: 5.29%Illumina(NASDAQ:ILMN)Holding Weight: 5.25%Regeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 5.24%Incyte(NASDAQ:INCY)Holding Weight: 5.15%Amgen(NASDAQ:AMGN)Holding Weight: 5.10%Gilead Sciences(NASDAQ:GILD)Holding Weight: 5.07%Vertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 5.07%Neurocrine Biosciences(NASDAQ:NBIX)Holding Weight: 4.86%Ionis Pharmaceuticals(NASDAQ:IONS)Holding Weight: 3.22%TG Therapeutics(NASDAQ:TGTX)Holding Weight: 3.18%PBE Sector ExposurePBE Industry ExposureFull Holdings Details Key ExecutivesH. Bruce BondChairman of the Board of Trustee, Chief Executive OfficerBruce T. DuncanChief Financial Officer, TreasurerKevin R. GustafsonChief Compliance OfficerKeith A OvittSecretaryRonn R. BaggeTrusteeMarc M KoleTrusteeD. Mark McMillanTrusteePhilip M. Nussbaum MbaTrusteeDonald H. WilsonTrusteeMore ExecutivesSimilar ETFsInvesco Pharmaceuticals ETFNYSEARCA:PJPSPDR S&P Health Care Equipment ETFNYSEARCA:XHEDirexion Daily Healthcare Bull 3x SharesNYSEARCA:CUREInvesco S&P SmallCap Health Care ETFNASDAQ:PSCHSPDR S&P Pharmaceuticals ETFNYSEARCA:XPHInstitutional OwnershipInstitute for Wealth Management LLC.Sold 157 shares on 7/25/2024Ownership: 0.514%Investment House LLCBought 450 shares on 7/22/2024Ownership: 0.189%Pacific Sun Financial CorpSold 260 shares on 7/19/2024Ownership: 0.173%Archford Capital Strategies LLCBought 5,508 shares on 7/17/2024Ownership: 0.136%GPS Wealth Strategies Group LLCBought 465 shares on 7/16/2024Ownership: 0.012%View All Institutional Transactions PBE ETF - Frequently Asked Questions How have PBE shares performed this year? Invesco Biotechnology & Genome ETF's stock was trading at $65.84 on January 1st, 2024. Since then, PBE shares have increased by 7.6% and is now trading at $70.8443. View the best growth stocks for 2024 here. Who are Invesco Biotechnology & Genome ETF's major shareholders? Top institutional investors of Invesco Biotechnology & Genome ETF include Institute for Wealth Management LLC. (0.51%), Newman Dignan & Sheerar Inc. (0.27%), Investment House LLC (0.19%) and Pacific Sun Financial Corp (0.17%). How do I buy shares of Invesco Biotechnology & Genome ETF? Shares of PBE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Invesco Biotechnology & Genome ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Invesco Biotechnology & Genome ETF investors own include Pfizer (PFE), Intel (INTC), Align Technology (ALGN), Micron Technology (MU), Activision Blizzard (ATVI), DocuSign (DOCU) and Inovio Pharmaceuticals (INO). This page (NYSEARCA:PBE) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Biotechnology & Genome ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Biotechnology & Genome ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
